163 related articles for article (PubMed ID: 305247)
1. [General pharmacological studies on tramadol, a potent analgetic agent (author's transl)].
Osterloh G; Friderichs E; Felgenhauer F; Günzler WA; Henmi Z; Kitano T; Nakamura M; Hayashi H; Ishii I
Arzneimittelforschung; 1978; 28(1a):135-51. PubMed ID: 305247
[TBL] [Abstract][Full Text] [Related]
2. [The effect of tramadol, a new analgesic, on respiration and cardiovascular function (author's transl)].
Vogel W; Burchardi H; Sihler K; Valic L
Arzneimittelforschung; 1978; 28(1a):183-6. PubMed ID: 580215
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological studies on analgesia, dependence on and tolerance of tramadol, a potent analgetic drug (author's transl)].
Friderichs E; Felgenhauer F; Jongschaap P; Osterloh G
Arzneimittelforschung; 1978; 28(1a):122-34. PubMed ID: 415746
[No Abstract] [Full Text] [Related]
4. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological properties of the main metabolite of flosequinan.
Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
[TBL] [Abstract][Full Text] [Related]
8. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
10. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
Engelhardt G
Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
[TBL] [Abstract][Full Text] [Related]
11. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
13. [On the pharmacodynamics of acemetacin (author's transl)].
Jacobi H; Dell HD
Arzneimittelforschung; 1980; 30(8A):1348-62. PubMed ID: 6968219
[TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
16. [On separation of isomeres, structural elucidation and pharmacological characterization of 1-(m-methoxyphenyl)-2-(dimethylaminomethyl)-cyclohexan-1-ol (author's transl)].
Frankus E; Friderichs E; Kim SM; Osterloh G
Arzneimittelforschung; 1978; 28(1a):114-21. PubMed ID: 580208
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological investigations with the combination sulfamoxole/trimethoprim, a new broadspectrum chemotherapeutic agent (author's transl)].
Gries J; Kretzschmar R; Kuhne J; Neumann W; Osterloh G; Scherschlicht R; Worstmann W
Arzneimittelforschung; 1976; 26(42):623-33. PubMed ID: 947323
[TBL] [Abstract][Full Text] [Related]
18. [The effect of tramadol on the EEG and the electronystagmogram (author's transl)].
Friedel B
Arzneimittelforschung; 1978; 28(1a):187-9. PubMed ID: 580216
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
[No Abstract] [Full Text] [Related]
20. Cardiac and hemodynamic effects of the centrally acting analgesics tramadol and pentazocine in anaesthetized rabbits and isolated guinea-pig atria and papillary muscles.
Müller B; Wilsmann K
Arzneimittelforschung; 1984; 34(4):430-3. PubMed ID: 6540101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
